Correlation Between Relmada Therapeutics and Broadridge Financial

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Relmada Therapeutics and Broadridge Financial at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Relmada Therapeutics and Broadridge Financial into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Relmada Therapeutics and Broadridge Financial Solutions, you can compare the effects of market volatilities on Relmada Therapeutics and Broadridge Financial and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Relmada Therapeutics with a short position of Broadridge Financial. Check out your portfolio center. Please also check ongoing floating volatility patterns of Relmada Therapeutics and Broadridge Financial.

Diversification Opportunities for Relmada Therapeutics and Broadridge Financial

-0.19
  Correlation Coefficient

Good diversification

The 3 months correlation between Relmada and Broadridge is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Relmada Therapeutics and Broadridge Financial Solutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Broadridge Financial and Relmada Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Relmada Therapeutics are associated (or correlated) with Broadridge Financial. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Broadridge Financial has no effect on the direction of Relmada Therapeutics i.e., Relmada Therapeutics and Broadridge Financial go up and down completely randomly.

Pair Corralation between Relmada Therapeutics and Broadridge Financial

Given the investment horizon of 90 days Relmada Therapeutics is expected to under-perform the Broadridge Financial. In addition to that, Relmada Therapeutics is 3.7 times more volatile than Broadridge Financial Solutions. It trades about -0.25 of its total potential returns per unit of risk. Broadridge Financial Solutions is currently generating about -0.16 per unit of volatility. If you would invest  20,234  in Broadridge Financial Solutions on January 25, 2024 and sell it today you would lose (726.00) from holding Broadridge Financial Solutions or give up 3.59% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Relmada Therapeutics  vs.  Broadridge Financial Solutions

 Performance 
       Timeline  
Relmada Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Relmada Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting primary indicators, Relmada Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Broadridge Financial 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Broadridge Financial Solutions has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Broadridge Financial is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Relmada Therapeutics and Broadridge Financial Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Relmada Therapeutics and Broadridge Financial

The main advantage of trading using opposite Relmada Therapeutics and Broadridge Financial positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Relmada Therapeutics position performs unexpectedly, Broadridge Financial can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Broadridge Financial will offset losses from the drop in Broadridge Financial's long position.
The idea behind Relmada Therapeutics and Broadridge Financial Solutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Fundamental Analysis
View fundamental data based on most recent published financial statements